HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Typo gremlin

This article was originally published in The Rose Sheet

Executive Summary

Typo gremlin: Commenting on the alleged link between talc use and ovarian cancer in a June 16 submission to FDA ("The Rose Sheet" June 26, p. 3), the Cosmetic, Toiletry, and Fragrance Association stated that "epidemiologic studies have provided weak and conflicting risk signals for [the] association [between talc use and ovarian cancer], and it is unlikely that further studies may prove adequate to raise concerns at a level sufficient to warrant regulatory or public health measures"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001797

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel